Institutional Ownership
Atyr Pharma Inc
CUSIP 002120202COM NEWATYRQ1 2026
13D / 13G Filings
37
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
19.4%
Max % of class reported
Institutional Holders
107
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
37 filings · latest Oct 7, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Oct 7, 2025 | Federated Hermes, Inc. | 13G/A | 10.8% | 10.54M | SEC |
| 2 | Jul 29, 2025 | The Vanguard Group | 13G | 5.2% | 4.66M | SEC |
| 3 | Jul 17, 2025 | Blackrock, Inc. | 13G | 6.5% | 5.76M | SEC |
| 4 | May 15, 2025 | Point72 Asset Management, L.P. | 13G/A | 3.2% | 2.85M | SEC |
| 5 | Jan 8, 2025 | Federated Hermes, Inc. | 13G/A | 17.5% | 14.67M | SEC |
| 6 | Nov 14, 2024 | Logos Global Management LP | 13G/A | 2.1% | 1.75M | SEC |
| 7 | Oct 15, 2024 | Point72 Asset Management, L.P. | 13G | 6.2% | 5.04M | SEC |
| 8 | Oct 7, 2024 | Federated Hermes, Inc. | 13G/A | 19.4% | 14.67M | SEC |
| 9 | Feb 14, 2024 | Lytton Laurence W | 13G/A | 1.0% | 585.0K | SEC |
| 10 | Feb 13, 2024 | Stonepine Capital Management, LLC | 13G/A | 0.8% | 482.3K | SEC |
27 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Atyr Pharma Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 14.71M | $11.47M |
| 2 | Federated Hermes, Inc. | 10.51M | $8.20M |
| 3 | Blackrock, Inc. | 6.44M | $5.03M |
| 4 | Ubs Group AG | 3.87M | $3.02M |
| 5 | Geode Capital Management, LLC | 2.39M | $1.86M |
| 6 | State Street Corp | 1.75M | $1.37M |
| 7 | Millennium Management LLC | 1.64M | $1.28M |
| 8 | Morgan Stanley | 1.23M | $955.9K |
| 9 | Two Sigma Investments, LP | 1.14M | $892.8K |
| 10 | Susquehanna International Group, LLP | 866.7K | $676.1K |